Aster Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.6K Buy
+142
New +$10.5K ﹤0.01% 766
2026
Q1
– Sell
-155
Closed -$6.39K – 1106
2025
Q4
$6.39K Buy
+155
New +$6.22K ﹤0.01% 831
2025
Q3
– Sell
-21,398
Closed -$592K – 1181
2025
Q2
$592K Buy
21,398
+19,942
+1,370% +$508K 0.13% 182
2025
Q1
$29.5K Buy
+1,456
New +$30K 0.01% 923

Other funds holding KNSA

Aster Capital Management's KNSA Position: Q3 2026 in Review

Aster Capital Management opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 142 shares worth $10.6K. The stake represents ﹤0.01% of the portfolio and ranks #766 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in KNSA as recently as Q4 2025.

Aster Capital Management first reported a position in KNSA in Q1 2025 and has held it in 4 quarters since. The position peaked at $592K in Q2 2025. 300 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Aster Capital Management held 142 shares of Kiniksa Pharmaceuticals worth $10.6K as of Q3 2026.
  • Kiniksa Pharmaceuticals was a new Aster Capital Management position in Q3 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #766 holding.
  • Aster Capital Management first reported a position in Kiniksa Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
  • Aster Capital Management's Kiniksa Pharmaceuticals position peaked at $592K in Q2 2025.
  • 300 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.